Cedar Holdings is an institutional-quality family office with a global mandate to invest in innovative and disruptive companies across public and private markets, primarily in the Healthcare and Technology sectors. Cedar has grown to over $750 million in assets and has investments around the world, including in the U.S., Western Europe, Scandinavia, Asia, and Latin America. Cedar strives to build long-term relationships with companies by engaging with them at different stages of their lifecycle, and offering its capital, expertise, and network to maximize growth opportunities and value. In addition to its public equity portfolio, Cedar has been involved in a number of successful private company exits and has capital invested in several high-performing funds. The firm has offices in New York, Boston, and London.

View More


Cedar believes we are in a renaissance period for healthcare. Greater scientific understanding, technological advances, regulatory progressiveness, harmonization in global clinical trial standards, a burgeoning life sciences ecosystem, and increasing availability of capital have created an unprecedented environment for biotechnology, pharmaceutical, medical device, and diagnostic companies.


Separately, the alarming growth rate of healthcare expenditures has exposed systemic inefficiencies which have created opportunities for insurance, healthcare services, and digital health firms. Significant legislative and regulatory overhauls have empowered these companies to counter the current cost trend and drive value across the supply chain.


Empowered by a focused yet flexible investment mandate, Cedar looks to capitalize on the opportunities and players that are best positioned to benefit from an evolving healthcare landscape.

Fund Investments


    Cedar Holdings

    125 Park Avenue, Suite 2516, New York, NY 10017